FDA Limits Use of Drug To Treat Lice

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&node=&contentId=A44241-2003Mar28&notFound=true

FDA Limits Use of Drug To Treat Lice

Associated Press

Saturday, March 29, 2003; Page A10

Using too much Lindane to treat lice infestations can cause deadly brain or nerve damage, federal health officials warned yesterday, stressing that the prescription drug should not be used on babies and "with great caution" on children.

The Food and Drug Administration took new steps to limit how much of the controversial drug people can slather on. Once sold in large bottles, Lindane now is to come only in one- or two-ounce packets for one-time use, and doctors are told not to prescribe more.

Lindane is an agricultural insecticide on which the Environmental Protection Agency imposes strong restrictions. Less-potent versions are sold as creams and shampoos to be rubbed into the scalp and skin to treat lice and scabies, a similar parasitic infection.

The products bear warnings that they can cause potentially fatal neurological damage.

The FDA said in 1996 that Lindane should be prescribed only to patients not helped by safer alternatives and warned against overuse.

© 2003 The Washington Post Company

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.